Search Results

2014 - Adding niacin plus laropiprant to statins did not reduce vascular events and increased serious adverse events.

• Authors : Bloomfield, Hanna E.¹

Subjects: *ANTILIPEMIC agents; *CARDIOVASCULAR diseases; *CARDIOVASCULAR diseases risk factorsCHINA; UNITED Kingdom; SCANDINAVIA

• Source: ACP Journal Club. 11/1/2014, Vol. 161 Issue 10, p1-1. 1p. 1 Chart.

Record details

2011 - Adding niacin to simvastatin did not improve clinical outcomes in patients with CV disease and dyslipidemia.

• Authors : Smith, Donald A.

Subjects: DRUG therapy for hyperlipidemia; ATHEROSCLEROSIS; CARDIOVASCULAR diseasesCANADA; UNITED States

• Source: ACP Journal Club. 4/17/2012, Vol. 156 Issue 4, p7-8. 2p.

Record details

Adding ezetimibe to simvastatin improved cardiovascular outcomes in stable acute coronary syndrome.

• Authors : Fordyce, Christopher B.¹; Granger, Christopher B.¹

Subjects: *ANTILIPEMIC agents; *CARDIOVASCULAR diseases risk factors; *CONFIDENCE intervals

• Source: ACP Journal Club. 9/15/2015, Vol. 163 Issue 6, p1-1. 1p. 1 Chart.

Record details

2012 - Review: Statins reduce pancreatitis in adults with normal or mildly elevated triglyceride levels.

• Authors : Bloomfield, Hanna E.¹

Subjects: *DRUG therapy for hyperlipidemia; *ANTILIPEMIC agents; *CONFIDENCE intervals

• Source: ACP Journal Club. 12/18/2012, Vol. 157 Issue 12, p1-1. 1p. 1 Chart.

Record details

Review: PCSK9 inhibitors reduce mortality but increase neurocognitive events in hypercholesterolemia.

• Authors : Santos, Raul D.¹

Subjects: *THERAPEUTIC use of protease inhibitors; *ANTILIPEMIC agents; *EZETIMIBE

• Source: ACP Journal Club. 3/15/2016, Vol. 164 Issue 6, p1-1. 1p. 1 Chart.

Record details

2017 - Evolocumab reduced CV events in patients with atherosclerotic CV disease taking high- or moderate-intensity statins.

• Authors : Jackson, Elizabeth¹; Eagle, Kim A.¹

Subjects: *CARDIOVASCULAR disease prevention; *DRUG therapy for hyperlipidemia; *STATINS (Cardiovascular agents)

• Source: ACP Journal Club. 7/18/2017, Vol. 167 Issue 2, p6-6. 1p. 1 Chart.

Record details

Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes.

• Authors : Bronson, David L.¹

Subjects: *ENZYME inhibitors; *DRUG therapy for hyperlipidemia; *DIABETIC retinopathyCANADA; UNITED States

• Source: ACP Journal Club. 11/16/2010, Vol. 153 Issue 5, p9-9. 1p. 1 Chart.

Record details

Ezetimibe plus simvastatin lowered lipid levels more than simvastatin monotherapy in primary hypercholesterolemia.

• Authors : Goldberg, A.C. .

Subjects: *LIPIDS; *HYPERCHOLESTEREMIA; *CHOLESTEROL

• Source: ACP Journal Club. Jan/Feb2005, Vol. 142 Issue 1, p16-16. 2/3p. 1 Chart.

Record details

COMMENTARY: Lipid-lowering reduce cardiovascular events in type 2diabetes.

• Authors : Gami, Apoor S.¹

Subjects: *DIABETES; *CARDIOVASCULAR diseases; *PATIENTS

• Source: ACP Journal Club. Nov/Dec2004, Vol. 141 Issue 3, p65-65. 1/3p.

Record details

Review: Lipid-lowering reduce cardiovascular events in type 2diabetes.

Subjects: *DIABETES; *CARBOHYDRATE intolerance; *CARDIOVASCULAR diseases

• Source: ACP Journal Club. Nov/Dec2004, Vol. 141 Issue 3, p65-65. 2/3p. 1 Chart.

Record details